Cargando…
Beyond T and DHT - Novel Steroid Derivatives Capable of Wild Type Androgen Receptor Activation
While androgen deprivation therapy (ADT) remains the primary treatment for metastatic prostate cancer (PCa), castration does not eliminate androgens from the prostate tumor microenvironment, and residual intratumoral androgens are implicated in nearly every mechanism by which androgen receptor (AR)-...
Autor principal: | Mostaghel, Elahe A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062953/ https://www.ncbi.nlm.nih.gov/pubmed/24948873 http://dx.doi.org/10.7150/ijbs.8844 |
Ejemplares similares
-
Steroid hormone synthetic pathways in prostate cancer
por: Mostaghel, Elahe A.
Publicado: (2013) -
Statins and adrenal androgen levels in prostate cancer: A new twist
por: Mostaghel, Elahe A
Publicado: (2021) -
SAT362 Low-dose DHT’s Effects On Gluconeogenesis And Energy Metabolism Are Ameliorated By Central Nervous System Knockout Of The Androgen Receptor
por: Ubba, Vaibhave, et al.
Publicado: (2023) -
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023) -
Fault Tolerant DHT-Based Routing in MANET
por: Zahid, Saleem, et al.
Publicado: (2022)